These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 34383488)

  • 21. Protein structure analysis of the interactions between SARS-CoV-2 spike protein and the human ACE2 receptor: from conformational changes to novel neutralizing antibodies.
    Mercurio I; Tragni V; Busto F; De Grassi A; Pierri CL
    Cell Mol Life Sci; 2021 Feb; 78(4):1501-1522. PubMed ID: 32623480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Silico analysis of interaction between full-length SARS-CoV2 S protein with human Ace2 receptor: Modelling, docking, MD simulation.
    Rui L; Haonan L; Wanyi C
    Biophys Chem; 2020 Dec; 267():106472. PubMed ID: 32916377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Machine Learning Approach to Identify Key Residues Involved in Protein-Protein Interactions Exemplified with SARS-CoV-2 Variants.
    Quitté L; Leclercq M; Prunier J; Scott-Boyer MP; Moroy G; Droit A
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2.
    Song W; Gui M; Wang X; Xiang Y
    PLoS Pathog; 2018 Aug; 14(8):e1007236. PubMed ID: 30102747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular screening of glycyrrhizin-based inhibitors against ACE2 host receptor of SARS-CoV-2.
    Ahmad S; Waheed Y; Abro A; Abbasi SW; Ismail S
    J Mol Model; 2021 Jun; 27(7):206. PubMed ID: 34169390
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Lapaillerie D; Charlier C; Fernandes HS; Sousa SF; Lesbats P; Weigel P; Favereaux A; Guyonnet-Duperat V; Parissi V
    Viruses; 2021 Feb; 13(3):. PubMed ID: 33669132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative analysis of ACE2 binding to coronavirus spike proteins: SARS-CoV-2
    Li Z; Zhang JZH
    Phys Chem Chem Phys; 2021 Jun; 23(25):13926-13933. PubMed ID: 34137759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of spike proteins on angiotensin converting enzyme 2 (ACE2).
    Bejoy J; Williams CI; Cole HJ; Manzoor S; Davoodi P; Battaile JI; Kaushik A; Nikolaienko SI; Brelidze TI; Gychka SG; Suzuki YJ
    Arch Biochem Biophys; 2023 Oct; 748():109769. PubMed ID: 37769892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Recognition Pathway of the SARS-CoV-2 Spike Receptor-Binding Domain to Human Angiotensin-Converting Enzyme 2.
    Peng C; Lv X; Zhang Z; Lin J; Li D
    Molecules; 2024 Apr; 29(8):. PubMed ID: 38675695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Computational decomposition reveals reshaping of the SARS-CoV-2-ACE2 interface among viral variants expressing the N501Y mutation.
    Socher E; Conrad M; Heger L; Paulsen F; Sticht H; Zunke F; Arnold P
    J Cell Biochem; 2021 Dec; 122(12):1863-1872. PubMed ID: 34516024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of potential SARS-CoV-2 entry inhibitors by targeting the interface region between the spike RBD and human ACE2.
    Gurung AB; Ali MA; Lee J; Farah MA; Al-Anazi KM
    J Infect Public Health; 2021 Feb; 14(2):227-237. PubMed ID: 33493919
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Virtual screening and molecular dynamics study of approved drugs as inhibitors of spike protein S1 domain and ACE2 interaction in SARS-CoV-2.
    Prajapat M; Shekhar N; Sarma P; Avti P; Singh S; Kaur H; Bhattacharyya A; Kumar S; Sharma S; Prakash A; Medhi B
    J Mol Graph Model; 2020 Dec; 101():107716. PubMed ID: 32866780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural Basis for Human Receptor Recognition by SARS-CoV-2 Omicron Variant BA.1.
    Geng Q; Shi K; Ye G; Zhang W; Aihara H; Li F
    J Virol; 2022 Apr; 96(8):e0024922. PubMed ID: 35343765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Receptor binding and priming of the spike protein of SARS-CoV-2 for membrane fusion.
    Benton DJ; Wrobel AG; Xu P; Roustan C; Martin SR; Rosenthal PB; Skehel JJ; Gamblin SJ
    Nature; 2020 Dec; 588(7837):327-330. PubMed ID: 32942285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative Perturbation-Based Modeling of the SARS-CoV-2 Spike Protein Binding with Host Receptor and Neutralizing Antibodies: Structurally Adaptable Allosteric Communication Hotspots Define Spike Sites Targeted by Global Circulating Mutations.
    Verkhivker GM; Agajanian S; Oztas DY; Gupta G
    Biochemistry; 2021 May; 60(19):1459-1484. PubMed ID: 33900725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Computational design of SARS-CoV-2 peptide binders with better predicted binding affinities than human ACE2 receptor.
    Sitthiyotha T; Chunsrivirot S
    Sci Rep; 2021 Aug; 11(1):15650. PubMed ID: 34341401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spike protein recognizer receptor ACE2 targeted identification of potential natural antiviral drug candidates against SARS-CoV-2.
    Pokhrel S; Bouback TA; Samad A; Nur SM; Alam R; Abdullah-Al-Mamun M; Nain Z; Imon RR; Talukder MEK; Tareq MMI; Hossen MS; Karpiński TM; Ahammad F; Qadri I; Rahman MS
    Int J Biol Macromol; 2021 Nov; 191():1114-1125. PubMed ID: 34592225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studying the Effects of ACE2 Mutations on the Stability, Dynamics, and Dissociation Process of SARS-CoV-2 S1/hACE2 Complexes.
    Hadi-Alijanvand H; Rouhani M
    J Proteome Res; 2020 Nov; 19(11):4609-4623. PubMed ID: 32786692
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular dynamics analysis of a flexible loop at the binding interface of the SARS-CoV-2 spike protein receptor-binding domain.
    Williams JK; Wang B; Sam A; Hoop CL; Case DA; Baum J
    Proteins; 2022 May; 90(5):1044-1053. PubMed ID: 34375467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural basis for the different states of the spike protein of SARS-CoV-2 in complex with ACE2.
    Yan R; Zhang Y; Li Y; Ye F; Guo Y; Xia L; Zhong X; Chi X; Zhou Q
    Cell Res; 2021 Jun; 31(6):717-719. PubMed ID: 33737693
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.